Accedi a banche dati online | Convegnodetail
Anteprima di stampa
 
 

4th Annual Neuropsychiatric Drug Development Summit | September 28-30, 2021 | Digital

Evvnt Promotion / evvnt
-
28.09.2021 - 30.09.2021  Online
Time: 8:30 am - 5:00 pm
 
Temi della conferenza
This last year has been a brutal reminder as to how crucial it is that we tackle the impending global mental health crisis and find a path towards successful neuropsychiatric drug development. We are proud to be the industry’s definitive and unrivalled forum focused on encapsulating the recent clinical advances across this extremely arduous field.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/791022-3?pid=4832

Speakers: Heather Dworak Senior Director, Clinical Research Sunovion, Daniel Mathalon Professor of Psychiatry and Behavioral Sciences UCSF Weill Institute for Neurosciences and more
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/791022-2?pid=4832
Mr. Customer Service
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
Conference + 1 Workshop - Drug Developer: USD 2898.00, Conference Only - Drug Developer: USD 2399.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

European Health Forum GasteinHilfswerk AustriaÖsterreichisches Rotes KreuzEuropean Public Health Association (EUPHA)Anästhesie in Entwicklungsländern e. V.Swiss Tropical and Public Health InstituteCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioÖsterreichische Akademie der Ärzte